Tudor Investment Corp’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,216
| Closed | -$66.9K | – | 1961 |
|
|
2025
Q1 | $66.9K | Hold |
6,216
| – | – | ﹤0.01% | 1448 |
|
|
2024
Q4 | $79.6K | Hold |
6,216
| – | – | ﹤0.01% | 1444 |
|
|
2024
Q3 | $172K | Hold |
6,216
| – | – | ﹤0.01% | 1427 |
|
|
2024
Q2 | $180K | Buy |
6,216
+1,916
| +45% | +$55.6K | ﹤0.01% | 1371 |
|
|
2024
Q1 | $192K | Buy |
+4,300
| New | +$192K | ﹤0.01% | 1327 |
|
|
2023
Q1 | – | Sell |
-6,240
| Closed | -$433K | – | 1814 |
|
|
2022
Q4 | $433K | Buy |
+6,240
| New | +$433K | 0.01% | 1168 |
|
|
2021
Q3 | – | Sell |
-598
| Closed | -$194K | – | 1794 |
|
|
2021
Q2 | $194K | Buy |
+598
| New | +$194K | ﹤0.01% | 1409 |
|